$50.00
Steglatro® (ertugliflozin) Tablets – Available in 5 mg and 15 mg
Product Description:
Steglatro® is an SGLT2 inhibitor containing ertugliflozin, prescribed for the treatment of type 2 diabetes in adults. By inhibiting the sodium-glucose co-transporter 2 (SGLT2), Steglatro helps lower blood sugar by preventing glucose reabsorption in the kidneys, leading to its excretion through urine. This mechanism helps reduce blood glucose levels, contributing to better overall glycemic control. Steglatro is often used in combination with diet and exercise and may be prescribed alongside other diabetes medications for improved management.
Product Features:
Active Ingredient: Ertugliflozin
Strengths: 5 mg or 15 mg per tablet
Dosage Form: Oral tablet
Quantity: Available in bottles of 30 tablets
Administration: Take once daily, with or without food, at the same time each day
Indications:
Type 2 Diabetes: Used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes
Adjunctive therapy: Can be used alone or in combination with other diabetes medications, including metformin, sulfonylureas, or insulin
Cardiovascular benefits: Steglatro may reduce the risk of heart failure-related hospitalizations and improve overall cardiovascular health for diabetic patients with heart complications
Reviews
There are no reviews yet.